| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $283.1M | +20.4% |
| Cost of Revenue | $32.7M | +15.6% |
| R&D Expense | $32.5M | +56.4% |
| SG&A Expense | $101.8M | -40.8% |
| Operating Income | $104.9M | +2338.4% |
| Pre-tax Income | $114.2M | +1432.7% |
| Income Tax | -$173.0M | — |
| Net Income | $287.2M | +4893.1% |
| EPS (Basic) | $2.14 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $80.2M | -3.9% |
| Accounts Receivable | $41.5M | +13.4% |
| Inventory | $45.7M | +16.5% |
| Current Assets | $492.0M | +10.2% |
| Total Assets | $751.6M | +36.5% |
| Current Liabilities | $93.7M | -4.1% |
| Total Liabilities | $170.3M | -1.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $135.7M | +205.6% |
| Investing Cash Flow | -$32.8M | -183.5% |
| Financing Cash Flow | -$106.1M | -116.1% |
| +5250.0% |
| EPS (Diluted) | $2.07 | +5075.0% |
| Stockholders' Equity |
| $581.3M |
| +54.0% |